EFFECTS OF METFORMIN ON GLUCOSE AND GLUCAGON REGULATED GLUCONEOGENESIS IN CULTURED NORMAL AND DIABETIC HEPATOCYTES
EFFECTS OF METFORMIN ON GLUCOSE AND GLUCAGON REGULATED GLUCONEOGENESIS IN CULTURED NORMAL AND DIABETIC HEPATOCYTES
复制标题
DOI:
10.1016/0006-2952(94)90365-4
复制
发表时间:
1994-08-30
影响因子:
5.8
通讯作者:
KHANDELWAL, RL
中科院分区:
文献类型:
--
作者:
YU, B;PUGAZHENTHI, S;KHANDELWAL, RL
The effects of glucose and glucagon on the anti-gluconeogenic action of metformin were investigated in normal and diabetic hepatocytes. Glucose production from lactate was elevated by 88% in hepatocytes from fasted normal rats compared with hepatocytes from fed animals. Diabetes caused 3.5- and 2.1-fold increases in hepatic gluconeogenesis under fasting and fed conditions, respectively. Metformin (250 mu M) suppressed glucose production by 37% in normal and by 30% in diabetic hepatocytes from fed rats. This drug was more effective (up to 67%) with increasing concentrations of glucose in the medium. Potentiation by metformin of insulin action on gluconeogenesis was elevated significantly (P < 0.01 to 0.001) by glucose in vitro. Metformin (75-250 mu M) also counteracted the effects of glucagon at optimal concentrations in normal (32-68%) as well as diabetic (8-46%) hepatocytes. The findings of this study indicate that (i) the anti-gluconeogenic effect of metformin is enhanced by glucose in vivo and in vitro; and (ii) the suppression of glucagon-induced gluconeogenesis by metformin could play a role in its glucose-lowering effects in diabetic conditions.